Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset MA Cooper, TA Fehniger, SC Turner, KS Chen, BA Ghaheri, T Ghayur, ... Blood, The Journal of the American Society of Hematology 97 (10), 3146-3151, 2001 | 1874 | 2001 |
Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours D Rakheja, KS Chen, Y Liu, AA Shukla, V Schmid, TC Chang, S Khokhar, ... Nature communications 5 (1), 4802, 2014 | 250 | 2014 |
p53 genes function to restrain mobile elements A Wylie, AE Jones, A D'Brot, WJ Lu, P Kurtz, JV Moran, D Rakheja, ... Genes & development 30 (1), 64-77, 2016 | 198 | 2016 |
DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors JF Amatruda, JA Ross, B Christensen, NJ Fustino, KS Chen, AJ Hooten, ... BMC cancer 13, 1-13, 2013 | 43 | 2013 |
A large T cell invagination with CD2 enrichment resets receptor engagement in the immunological synapse K Singleton, N Parvaze, KR Dama, KS Chen, P Jennings, B Purtic, ... The Journal of Immunology 177 (7), 4402-4413, 2006 | 43 | 2006 |
Mutations in microRNA processing genes in Wilms tumors derepress the IGF2 regulator PLAG1 KS Chen, EK Stroup, A Budhipramono, D Rakheja, D Nichols-Vinueza, ... Genes & development 32 (15-16), 996-1007, 2018 | 40 | 2018 |
Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides KS Chen, A Bach, A Shoup, NJ Winick Pediatric blood & cancer 60 (11), 1772-1777, 2013 | 32 | 2013 |
EGF receptor and mTORC1 are novel therapeutic targets in nonseminomatous germ cell tumors KS Chen, NJ Fustino, AA Shukla, EK Stroup, A Budhipramono, C Ateek, ... Molecular cancer therapeutics 17 (5), 1079-1089, 2018 | 18 | 2018 |
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma KS Chen, WS Kwon, J Kim, SJ Heo, HS Kim, HK Kim, SH Kim, WS Lee, ... Molecular Case Studies 2 (5), a000992, 2016 | 15 | 2016 |
Distinct DICER1 hotspot mutations identify bilateral tumors as separate events KS Chen, SH Stuart, EK Stroup, AS Shukla, J Wang, V Rajaram, ... JCO precision oncology 2, 2018 | 13 | 2018 |
Integrated molecular analysis reveals 2 distinct subtypes of pure seminoma of the testis KE Medvedev, AV Savelyeva, KS Chen, A Bagrodia, L Jia, NV Grishin Cancer informatics 21, 11769351221132634, 2022 | 10 | 2022 |
External validation and comparison of magnetic resonance imaging-based predictive models for clinically significant prostate cancer HJ Lee, A Lee, XY Yang, YM Law, HH Huang, WKO Lau, LS Lee, HSS Ho, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 783. e1-783 …, 2021 | 8 | 2021 |
WT‐CLS1 is a rhabdoid tumor cell line and can be inhibited by miR‐16 EK Stroup, Y Yeu, A Budhipramono, TH Hwang, D Rakheja, ... Cancer reports 2 (3), e1110, 2019 | 7 | 2019 |
Evolving trends in the surgical management of renal masses over the past two decades: A contemporary picture from a large prospectively‐maintained database K Chen, A Lee, HH Huang, KJ Tay, A Sim, LS Lee, CWS Cheng, LG Ng, ... International Journal of Urology 26 (4), 465-474, 2019 | 6 | 2019 |
A big catch for germ cell tumour research KS Chen, JF Amatruda PLoS genetics 9 (4), e1003481, 2013 | 6 | 2013 |
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence L Xu, JL Pierce, A Sanchez, KS Chen, AA Shukla, NJ Fustino, SH Stuart, ... Nature communications 14 (1), 2636, 2023 | 5 | 2023 |
Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor CR Fraire, PR Mallinger, JN Hatton, J Kim, DS Dickens, PA Argenta, ... JCO precision oncology 7, e2300189, 2023 | 4 | 2023 |
Specifications of the ACMG/AMP Variant Classification Guidelines for Germline DICER1 Variant Curation JN Hatton, MN Frone, HC Cox, SB Crowley, S Hiraki, NN Yokoyama, ... Human mutation 2023, 2023 | 4 | 2023 |
Extrarenal anaplastic Wilms tumor: a case report with genomic analysis and tumor models KR Willis, AA Sathe, C Xing, P Koduru, M Artunduaga, EB Butler, JY Park, ... Journal of pediatric hematology/oncology 44 (4), 147-154, 2022 | 4 | 2022 |
Wilms tumor mutational subclasses converge to drive CCND2 overexpression L Xu, K Desai, J Kim, Q Zhou, L Guo, X Xiao, Y Zhang, L Zhou, A Yuksel, ... medRxiv, 2023 | 2 | 2023 |